ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, announced that Joe Bolen, Ph.D., an Executive Partner at MPM BioImpact, former Chief Scientific Officer at PureTech Health and former President of Research and Development of Moderna Therapeutics, will serve as the company’s first Chief Science Innovation Officer. “Joe is a pioneering scientist and…
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, announced the appointment of Paul Perreault to its Board of Directors, effective December 5, 2023. Perreault most recently served as Chief Executive Officer of CSL and brings over 40 years of leadership experience across the biotechnology industry. “Paul is a distinguished industry executive recognized…